All In MedTech

Device Trial Radar · NCT06219252

Intraoperative Aberrometry vs Conventional Intraocular Lens Calculation, a Prospective Study.

Intraoperative Aberrometry vs Conventional Introcular Lens Calculation ( Barrett Universal II / Barrett True K ), Refractive and Visual Outcomes, a Prospective Study.

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Nov 3, 2023

Primary completion

Nov 30, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Instituto de Oftalmología Fundación Conde de ValencianaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 23, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

the goal of this intervention study is to compare prospectively the accuracy of the power calculation between both groups, the intraoperative aberrometry (ORA) vs barrett universal II preoperative calculation (control group) . Researchers will compare ORA group vs control to see changes in spherical equivalent and uncorrected distance visual acuity

Conditions

  • Intraocular Lens Implantation
  • Cataract
  • Humans
  • Ocular, Refraction

Interventions

  • Intraoperative aberrometerDevice

    the patient intraocular lens will be optimized during the aphakic period after cataract extraction and before intraocular lens implantation, this will produce a possible change in the dioptric power of the intraocular lens

  • Preoperative intraocular lens calculationOther

    the intraocular lens in this group will be calculated preoperatively with Barrett Universal II formula

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. spherical equivalentTime frame: 90 days of the postoperative period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Instituto de oftalmología Fundación Conde de Valenciana

    Mexico City, Cuauhtemoc, Mexico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.